Skip to main content
. 2020 Jul 28;11(30):2889–2905. doi: 10.18632/oncotarget.27587

Figure 10. Clinical relevance of HAS2 in TCGA METABRIC dataset of human breast cancer.

Figure 10

(A) Oncoprint showing genomic alterations in VDR, HAS1, HAS2, and HAS3 in 1904 human breast tumors. Each column of light grey bars in this scheme represents one case of human breast cancer; colored bars indicate specific types of genomic alterations as indicated in the legend. (B) Kaplan Meier analysis of overall survival in METABRIC dataset stratified by HAS2 alterations. (C) HAS2 alterations according to breast cancer subtype. (D) Correlation between HAS2 and GFPT2 expression. All data were calculated from publicly accessible METABRIC database at cBio Cancer Genomics Portal.